Cardiac Failure ReviewPub Date : 2026-09-08eCollection Date: 2026-01-01DOI: 10.15420/cfr.2026.05
Faraz Pathan, Kathryn Williams
{"title":"Obesity in Heart Failure: Mechanistic, Diagnostic and Therapeutic Considerations.","authors":"Faraz Pathan, Kathryn Williams","doi":"10.15420/cfr.2026.05","DOIUrl":"10.15420/cfr.2026.05","url":null,"abstract":"<p><p>The prevalence of obesity among the general population has resulted in significant overlap and complex interactions with heart failure. This review aims to describe recent changes to the definition of obesity and explore direct and indirect mechanistic links between obesity and heart failure. Diagnostic challenges presented by obesity regarding echocardiography and B-type natriuretic peptide are also explored. Treatment options and the evidence base for addressing obesity in heart failure are examined across both heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Finally, the safety profile of new incretin-based therapies is examined.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e26"},"PeriodicalIF":12.2,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13595267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149025674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiac Failure ReviewPub Date : 2026-08-21eCollection Date: 2026-01-01DOI: 10.15420/cfr.2026.19
Clara Saldarriaga
{"title":"Hypertrophic Cardiomyopathy in the Era of Precision Medicine: Redefining Diagnosis, Therapeutics and Risk.","authors":"Clara Saldarriaga","doi":"10.15420/cfr.2026.19","DOIUrl":"10.15420/cfr.2026.19","url":null,"abstract":"","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e25"},"PeriodicalIF":12.2,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13573012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148971692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiac Failure ReviewPub Date : 2026-08-21eCollection Date: 2026-01-01DOI: 10.15420/cfr.2025.49
Anika S Naidu, Ovidiu Chioncel, Jolie Bruno, Javed Butler, Andrew Js Coats, Sean P Collins, Gad Cotter, Beth Davison, Zara Fatima, Oliviana Geavlete, Nicolas Girerd, Shir Lynn Lim, Alexandre Mebazaa, Marco Metra, Òscar Miró, Alberto Palazzuoli, Marija Polovina, Razvan I Radu, Gianluigi Savarese, Dana R Sax, Petar M Seferovic, Maurizio Volterrani, Andrew P Ambrosy
{"title":"Precipitants of Acute Heart Failure: A State-of-the-art Review from an International Expert Group.","authors":"Anika S Naidu, Ovidiu Chioncel, Jolie Bruno, Javed Butler, Andrew Js Coats, Sean P Collins, Gad Cotter, Beth Davison, Zara Fatima, Oliviana Geavlete, Nicolas Girerd, Shir Lynn Lim, Alexandre Mebazaa, Marco Metra, Òscar Miró, Alberto Palazzuoli, Marija Polovina, Razvan I Radu, Gianluigi Savarese, Dana R Sax, Petar M Seferovic, Maurizio Volterrani, Andrew P Ambrosy","doi":"10.15420/cfr.2025.49","DOIUrl":"10.15420/cfr.2025.49","url":null,"abstract":"<p><p>Acute heart failure (AHF) is a leading cause of hospitalisation worldwide, with the majority of cases triggered by an identifiable precipitant. Recognition of these precipitants is important for both acute management and long-term prevention, as they are frequently reversible, carry prognostic significance and directly inform targeted therapy. The epidemiology of precipitants varies across settings, and patterns are evolving as the prevalence of heart failure with preserved ejection fraction rises. In this review, we summarise the epidemiology, diagnostic evaluation and management of the most common precipitants of AHF. Globally, the leading precipitants of AHF are ischaemia/acute coronary syndrome, infection, arrhythmias, uncontrolled hypertension, nonadherence and renal dysfunction, although their relative distribution varies by geography and heart failure phenotype. Optimal medical management necessitates initial haemodynamic stabilisation, identification of the underlying precipitant and delivery of targeted therapy. Importantly, successful identification and treatment of a reversible precipitant should not preclude initiation or optimisation of guideline-directed medical therapy, which remain essential for long-term outcomes.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e24"},"PeriodicalIF":12.2,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13573020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148971634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiac Failure ReviewPub Date : 2026-08-19eCollection Date: 2026-01-01DOI: 10.15420/cfr.2025.47
Madison Rosen, Lee R Goldberg
{"title":"When the Heart Meets the Pillow: Building Cross-disciplinary Solutions for Sleep-disordered Breathing.","authors":"Madison Rosen, Lee R Goldberg","doi":"10.15420/cfr.2025.47","DOIUrl":"10.15420/cfr.2025.47","url":null,"abstract":"<p><p>The interplay between sleep-disordered breathing (SDB) and cardiovascular disease, particularly arrhythmias and heart failure, is complex and bidirectional. This article examines the impact of SDB in cardiovascular disease and heart failure. It is proposed that teams interested in improving SDB diagnosis and management take ACTION (assess for risk factors/screening in each visit; collaborate with sleep colleagues for referrals/visits; test for SDB with home sleep apnoea test, polysomnography; intervene with SDB-specific treatment (oral devices, continuous positive airway pressure, bilevel positive airway pressure, phrenic nerve and hypoglossal nerve stimulators) including risk factor modification (weight reduction, alcohol abstinence); continue ongoing assessment by cardiology and sleep teams for feedback about treatment; creating niche programmes for AF, heart failure and weight loss.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e23"},"PeriodicalIF":12.2,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13573019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148971711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiac Failure ReviewPub Date : 2026-08-17eCollection Date: 2026-01-01DOI: 10.15420/cfr.2026.02
Carlos Escobar, Pedro Caravaca-Pérez, José Maria Fernandez-Rodriguez, Ines Gomez-Otero, Ainara Lozano-Bahamonde, Alejandro I Pérez-Cabeza, José Pérez-Silvestre, Carles Rafols, Jesús Saldaña-García, Alberto Esteban-Fernández
{"title":"Estimating the Benefits of the Comprehensive Disease-modifying Pharmacological Treatment in Patients with Heart Failure.","authors":"Carlos Escobar, Pedro Caravaca-Pérez, José Maria Fernandez-Rodriguez, Ines Gomez-Otero, Ainara Lozano-Bahamonde, Alejandro I Pérez-Cabeza, José Pérez-Silvestre, Carles Rafols, Jesús Saldaña-García, Alberto Esteban-Fernández","doi":"10.15420/cfr.2026.02","DOIUrl":"10.15420/cfr.2026.02","url":null,"abstract":"<p><p>To determine the effects of the comprehensive disease-modifying pharmacological approach among patients with heart failure with reduced ejection fraction, a cross-trial, aggregate-data analysis was performed to estimate the expected combined effect of quintuple therapy by multiplying trial-level HRs, assuming independent and multiplicative treatment effects from Phase III randomised clinical trials: EMPHASIS-HF, PARADIGM-HF, pooled DAPA-HF and EMPEROR-Reduced, and pooled VICTORIA and VICTOR. The imputed aggregate treatment effects on the primary endpoint of cardiovascular death or first heart failure hospitalisation were favourable to the quintuple compared with conventional therapy (HR 0.34; 95% CI [0.27-0.42]). This also occurred for cardiovascular death alone (HR 0.47; 95% CI [0.35-0.63]), first heart failure hospitalisation (HR 0.31; 95% CI [0.23-0.40]) and all-cause mortality (HR 0.51; 95% CI [0.39-0.67]). The numbers needed to treat per year for the primary outcome, cardiovascular death and first heart failure hospitalisation were 10, 23 and 15, respectively. Our findings support the potential benefit of comprehensive therapy, with the incremental role of vericiguat likely greatest in higher-risk patients or those with recent worsening heart failure.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e22"},"PeriodicalIF":12.2,"publicationDate":"2026-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13573018/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148971694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiac Failure ReviewPub Date : 2026-08-12eCollection Date: 2026-01-01DOI: 10.15420/cfr.2026.16
So Ree Kim, Dong-Hyuk Cho, Mi-Na Kim, Jung-Joon Cha, Bo Ryun Kim, Jeong Hoon Yang, Seong-Mi Park
{"title":"Relationship of Cardiopulmonary Exercise Capacity to Coronary Microvascular Function and Body Composition in Patients with Suspected Heart Failure with Preserved Ejection Fraction.","authors":"So Ree Kim, Dong-Hyuk Cho, Mi-Na Kim, Jung-Joon Cha, Bo Ryun Kim, Jeong Hoon Yang, Seong-Mi Park","doi":"10.15420/cfr.2026.16","DOIUrl":"10.15420/cfr.2026.16","url":null,"abstract":"<p><strong>Background: </strong>Exercise intolerance in heart failure reflects heterogeneous mechanisms, including coronary microvascular dysfunction (CMD), obesity and sarcopenia. The aim of this study was to investigate the relationships between cardiopulmonary exercise capacity, coronary microvascular function and body composition in patients with suspected heart failure with preserved ejection fraction (HFpEF).</p><p><strong>Methods: </strong>In this single-centre cross-sectional study, consecutive patients presenting with chest discomfort or dyspnoea and an intermediate or high probability of HFpEF were enrolled. All patients underwent body composition analysis, adenosine stress echocardiography for coronary flow reserve (CFR) and cardiopulmonary exercise testing to assess peak oxygen consumption (VO<sub>2</sub> peak).</p><p><strong>Results: </strong>Of the 101 patients (mean age 63 years; 52.0% women), CMD (CFR <2.5) was present in 40.6%. Mean VO<sub>2</sub> peak was 23.0 ± 5.3 ml/min/kg. Patients with lower VO<sub>2</sub> peak (<23 ml/min/kg) had higher visceral fat area and percentage body fat. VO<sub>2</sub> peak correlated positively with CFR (r=0.344, p<0.001) and septal e' velocity and inversely with E/e'. Skeletal muscle mass index correlated positively with VO<sub>2</sub> peak predominantly in obese patients (BMI ≥25 kg/m<sup>2</sup>). In multivariable analysis, both CFR and degree of body fat remained independent correlates of VO<sub>2</sub> peak.</p><p><strong>Conclusion: </strong>In patients with suspected HFpEF, cardiopulmonary exercise capacity is closely associated with left ventricular diastolic function, coronary microvascular function and body composition. Preserved skeletal muscle mass may mitigate the adverse impact of obesity on exercise performance. These findings highlight the importance of integrated assessment of CMD and body composition and support targeted lifestyle and exercise interventions to improve functional capacity in HFpEF phenotypes.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e20"},"PeriodicalIF":12.2,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13573011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148971650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiac Failure ReviewPub Date : 2026-08-12eCollection Date: 2026-01-01DOI: 10.15420/cfr.2026.04
Sheizaf Gefen, Ofer Havakuk, Lior Zornitzki, Shir Frydman, Michal Laufer-Perl, Daniel Karlsberg, Yoav Granot
{"title":"Association Between Diastolic Dysfunction and Postoperative Heart Failure in Non-cardiac Surgeries.","authors":"Sheizaf Gefen, Ofer Havakuk, Lior Zornitzki, Shir Frydman, Michal Laufer-Perl, Daniel Karlsberg, Yoav Granot","doi":"10.15420/cfr.2026.04","DOIUrl":"10.15420/cfr.2026.04","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular complications are a leading cause of morbidity and mortality following non-cardiac surgery. Although the association between systolic dysfunction and perioperative outcomes is well recognised, the prognostic significance of diastolic dysfunction remains underexplored and is not incorporated into risk models. This study investigated whether preoperative diastolic dysfunction is associated with adverse in-hospital outcomes following non-cardiac surgery.</p><p><strong>Methods: </strong>This retrospective cohort study included 3,882 adults who underwent non-cardiac surgery between 2011 and 2021 and had preoperative echocardiographic assessment of diastolic function. Diastolic dysfunction was graded per 2016 American Society of Echocardiography guidelines and categorised as normal/grade 1 (normal left-sided filling pressure [NLFP]) or grade 2/3 (elevated left-sided filling pressure [ELFP]). The primary outcome was a composite of in-hospital mortality and acute heart failure.</p><p><strong>Results: </strong>The primary outcome occurred in 22.3% of patients with ELFP and 11.6% of patients with NLFP (OR 2.1; 95% CI [1.7-2.6]; p<0.001). In-hospital mortality was 9.1% in the ELFP group and 4.2% in the NLFP group (OR 2.2; 95% CI [1.6-3.0]). Pulmonary oedema (3.8% versus 0.7%; OR 4.9; 95% CI [2.9-8.4]), furosemide use (12.9% versus 5.5%; OR 2.5; 95% CI [1.9-3.2]) and vasoactive medication administration (7.9% versus 5.4%; OR 1.5; 95% CI [1.1-2]) were more frequent in the ELFP group. These associations persisted after adjustment for echocardiographic and clinical parameters. Stratified analysis showed the association was strongest in intermediate- to high-risk surgeries.</p><p><strong>Conclusion: </strong>Diastolic dysfunction is independently associated with adverse postoperative outcomes in non-cardiac surgery. Incorporating diastolic parameters into preoperative risk assessment may improve perioperative outcomes.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e21"},"PeriodicalIF":12.2,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13573010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148971666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiac Failure ReviewPub Date : 2026-08-03eCollection Date: 2026-01-01DOI: 10.15420/cfr.2025.60
Simon M Kaplan, Richard B Berry, William T Abraham
{"title":"The 2025 American Academy of Sleep Medicine Central Sleep Apnoea Guidelines and the Heart Failure Patient.","authors":"Simon M Kaplan, Richard B Berry, William T Abraham","doi":"10.15420/cfr.2025.60","DOIUrl":"10.15420/cfr.2025.60","url":null,"abstract":"<p><p>Central sleep apnoea (CSA) and Cheyne-Stokes respiration are prevalent in patients with heart failure and contribute to disease progression, increased risk of death, heart failure hospitalisations and reduced quality of life. The 2025 American Academy of Sleep Medicine Clinical Practice Guideline for the Treatment of Central Sleep Apnea in Adults represents a major advance, recognising transvenous phrenic nerve stimulation as an evidence-based therapy for adults with CSA, including those with heart failure, as well as updating the clinical data on adaptive servo-ventilation. This review summarises key updates in the American Academy of Sleep Medicine 2025 guideline, examines the pathophysiological link between CSA and heart failure, and evaluates the clinical evidence and practical considerations for treatment. Current evidence indicates improvements in apnoea indices, oxygenation and quality of life, while the effect on mortality and hospitalisation needs additional prospective randomised data. Identification of patients with signs and symptoms which are likely due to central sleep apnoea is often missed in clinical practice, and treatment has a significant impact on quality of life.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e18"},"PeriodicalIF":12.2,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13458398/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148713745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiac Failure ReviewPub Date : 2026-08-03eCollection Date: 2026-01-01DOI: 10.15420/cfr.2025.48
Cristiana Vitale, Gabriele Fragasso, Izabella Uchmanowicz, Angela Sciacqua, Pablo Díez-Villanueva, Shirley Sze, Quin E Denfeld, Markus S Anker, Elena Marques-Sule, Anna Strömberg, Emanuelle Berthelot, Stephan von Haehling, Giuseppe Rosano, Wolfram Doehner, Yuhui Zhang, Camilla Hage
{"title":"Multidimensional and Multidisciplinary Management of Heart Failure Patients with Frailty.","authors":"Cristiana Vitale, Gabriele Fragasso, Izabella Uchmanowicz, Angela Sciacqua, Pablo Díez-Villanueva, Shirley Sze, Quin E Denfeld, Markus S Anker, Elena Marques-Sule, Anna Strömberg, Emanuelle Berthelot, Stephan von Haehling, Giuseppe Rosano, Wolfram Doehner, Yuhui Zhang, Camilla Hage","doi":"10.15420/cfr.2025.48","DOIUrl":"10.15420/cfr.2025.48","url":null,"abstract":"<p><p>This paper discusses the considerations for multidimensional and multidisciplinary management of heart failure (HF) patients with frailty. Frailty is a multidimensional, dynamic and potentially reversible state, defined by clinical, functional, psycho-cognitive and social domains. Frailty is seldom systematically assessed in clinical practice in HF patients. Paradoxically, although the absolute benefit of HF guideline-directed medical treatment in frail HF patients seems greater, it is under-prescribed. This therapeutic gap could be related to different reasons, such as concerns about safety, polypharmacy and the lack of specific evidence-based data. Frail HF patients require a comprehensive, multidimensional therapeutic strategy that integrates available evidence-based pharmacological interventions with targeted non-pharmacological modalities across multiple clinical disciplines to optimise patient outcomes. The four domains of frailty should be objectively and routinely assessed with a multidimensional approach to facilitate a more individualised and comprehensive care plan delivered by a multidisciplinary team. In the future, we need more dedicated studies and randomised clinical trials that include frail HF patients.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e19"},"PeriodicalIF":12.2,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13458406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148713183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiac Failure ReviewPub Date : 2026-07-14eCollection Date: 2026-01-01DOI: 10.15420/cfr.2025.51
Oliviana Geavlete, Andrew P Ambrosy, Alexandre Mebazaa, Sean P Collins, Jan Biegus, Marianna Adamo, John Teerlink, Giuseppe Mc Rosano, Petar Seferović, Razvan I Radu, Gianluigi Savarese, Beth Davison, Alexandru Ababei, Marija Polovina, Anika Naidu, Òscar Miró, Luca Monzo, Alberto Palazzuoli, Teodora Radu, Lars H Lund, Tuvia Ben Gal, Maurizio Volterrani, Ovidiu Chioncel, Gad Cotter, Mandeep R Mehra, Javed Butler, Andrew Js Coats, Vlad Iliescu
{"title":"Liver Function Abnormalities in Acute Heart Failure: A State-of-the-art Review from an International Expert Group.","authors":"Oliviana Geavlete, Andrew P Ambrosy, Alexandre Mebazaa, Sean P Collins, Jan Biegus, Marianna Adamo, John Teerlink, Giuseppe Mc Rosano, Petar Seferović, Razvan I Radu, Gianluigi Savarese, Beth Davison, Alexandru Ababei, Marija Polovina, Anika Naidu, Òscar Miró, Luca Monzo, Alberto Palazzuoli, Teodora Radu, Lars H Lund, Tuvia Ben Gal, Maurizio Volterrani, Ovidiu Chioncel, Gad Cotter, Mandeep R Mehra, Javed Butler, Andrew Js Coats, Vlad Iliescu","doi":"10.15420/cfr.2025.51","DOIUrl":"10.15420/cfr.2025.51","url":null,"abstract":"<p><p>Acute heart failure (AHF) is a systemic condition characterised by multiorgan involvement that varies from subclinical to overt organ failure. The liver is particularly vulnerable due to its dual blood supply and sensitivity to haemodynamic and inflammatory disturbances. Abnormal liver function tests are highly prevalent in patients with AHF, reflecting major mechanisms: passive hepatic venous congestion from elevated central venous pressure, hepatocellular ischaemia from low cardiac output, systemic inflammation and poor metabolic status associated with cachexia. In patients with AHF, liver function tests at admission, during hospitalisation and at discharge are independently associated with rehospitalisation, cardiovascular and all-cause mortality. Persistent abnormalities after hospitalisation often reflect incomplete decongestion or irreversible structural liver changes. Therapeutic strategies focus on decongestion, optimisation of cardiac output and medication adjustments to avoid hepatotoxicity. Despite significant advances in understanding cardio-hepatic interactions, major gaps remain, including the lack of standardised definitions, limited mechanistic studies and the underrepresentation of patients with heart failure with preserved ejection fraction in contemporary research. Future research should explore targeted therapies to improve cardiohepatic interactions and patient outcomes.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"12 ","pages":"e17"},"PeriodicalIF":12.2,"publicationDate":"2026-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13392301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148580408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}